AC Immune announces a research and development collaboration in neurodegenerative diseases with Biogen Apr 18, 2016 English 252.9 KB Français 252.2 KB Deutsch 251.8 KB R&D collaboration to develop PET-ligands for two protein targets involved in pathogenesis of neurodegenerative diseases - alpha-synuclein and TDP43